April 2018 | Volume 1

The orthopaedic industry's supply chain was shaken up by NN's acquisition of Paragon Medical for US $375MM in cash. What does this mean for you? What's next for NN?

Mr. Namal Nawana's experience includes 15+ years with Johnson & Johnson, primarily in the Medical Devices and Diagnostics segment. He steps in to lead a company that has struggled with growth in recent years.

Our regulatory expert outlines the roles of manufacturers selling in the U.S., FDA and U.S. Customs as they relate to the increasing scrutiny of international purchasing controls.

1,001+ participants | 230 companies
50 speakers | 29 sessions

OMTEC's speakers are surgeons, entrepreneurs, CEOs, VPs and engineers.
Reap the benefits of their perspectives and wise counsel...attend OMTEC!


Contact any exhibitor for a promo code to save on your registration!

New stemless shoulder devices could be a significant growth driver for companies' upper extremities portfolios. This is the message from analysts as  Exactech's recently FDA-cleared Equinoxe is seen as direct competition for Wright Medical and Zimmer Biomet's offerings.
Japanese researchers found that a use of a patented titanium fiber plate did not yield bone embrittlement after close contact with the bone for prolonged periods. Developers believe that the material could eliminate plate extraction and associated surgical risks in fracture repair.  

The increasing feature complexity of tight tolerance parts can be a challenge for orthopaedic device companies. Profile tolerancing may be the solution you seek.
Brain scans have shown that mindfulness may change the way our brains function and help us improve attention, reduce stress hormones and even bounce back faster from negative information.